UPMC-Magee Womens Hospital — Pittsburgh, Pennsylvania

UPMC-Magee Womens Hospital is a clinical research site located in Pittsburgh, Pennsylvania, United States 15213.

Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

UPMC-Magee Womens Hospital has participated in 125 clinical trials with 79 currently active.

Therapeutic areas: Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor, FIGO Stage II Gestational Trophoblastic Tumor.

Sponsors: GOG Foundation, National Cancer Institute (NCI), SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UPMC-Magee Womens Hospital?

UPMC-Magee Womens Hospital has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UPMC-Magee Womens Hospital conducted?

UPMC-Magee Womens Hospital has 125 clinical trials on record, with 79 currently active. Their work covers Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor, FIGO Stage II Gestational Trophoblastic Tumor.

Is UPMC-Magee Womens Hospital accredited by Crixeo Health?

UPMC-Magee Womens Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UPMC-Magee Womens Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.